Post on 04-Apr-2018
82
DAFTAR PUSTAKA
1. Ozougwu, J. C.1, Obimba, K. C.2, Belonwu, C. D.3, and Unakalamba, C. B.
The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus.
Journal of Physiology and Pathofisiology. 2013 Sep 4 (4): 46-57.
2. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diab Care; 2013: S67-74.
3. Hyun Soon Lee. Mechanisms and Consequences of TGF-ß Overexpression by
Podocytes in Progressive Podocyte Disease. 2012; 347(1): 129–140.
4. Francisco J. López-Hernández & Jose M. López-Novoa. Role of TGF-β in
chronic kidney disease: an integration of tubular, glomerular and vascular
effects. Cell Tissue Res (2012) 347:141–154
5. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-Beta as
the major mediator. J Am Soc Nephrol 2004;15: S55-7
6. Lee HS, Song CY. Differential role of mesangial cells and podocytes in TGF-
beta-induced mesangial matrix synthesis in chronic glomerular disease. 2009
Jul;24(7):901-8.
7. A. Iswara. Efek Pemberian Morinda citrfolia Pada Ginjal Diabetes Nefropaty
Tikus Spraque Dawley Diabetes Diinduksi STZ; Dengan Kajian Kadar
Albumin Urin, TGF-ß serum dan Ekspresi Kolagen. 2011. Tesis Biomedik
Undip.
8. Lee Wei Har, Intan safinar Ismail. Antioksidant Activity Total Phenolics and
Total flavonoids of Syzygium polyanthum (Wight) Walp Leaves. June 2012;
2(2): 219-288.
9. Djoko Wahyono, Susanti Aktivitas Hipoglikemik Ekstrak Etanolik Daun
Salam (Syzygium polyanthum (Wight) Walp) Dan Pengaruhnya Terhadap
Stimulasi Parasimpatik Pada Kelinci Jantan Yang Dibebani Glukosa.
10. Widharna RM, Ferawati, Herdiati L, Surjadhana A, Jonosewojo A,
Widjajakusuma EC. Antidiabetic Properties of Andrographis peniculata Nees
and Eugenia polyantha Wight Leaves in Wistar Rats by Oral Glucose
Tolerance Test. Jurnal Tumbuhan Obat Indonesia. Des 2010; 3 (2).
11. Lelono, RAA; Tachibana, Sanro. Preliminary Studies of Indonesian Eugenia
polyantha Leaf Extracts as Inhibitors of Key Enzymes for Type 2 Diabetes.
Journal of Medical Sciences 13.2 (2013): 103-110
83
12. Perumal S, Mahmud R, Piaru SP, et al. Potenstial antiradical activity and
cytotoxicity assessment of Ziziphus mauritiana and Syzygium polyanthum. Int
J of Pharm. 2012;8(6): 534-41.
13. Szkudelski T, The Mechanism of Alloxan and Streptozotocin Action in ß-Cell
of the Rat Pancreas, Physiological Research, 2001; (50) 536-546
14. Partini Pudjiastuti Trihono. Peran Transforming Growth Factor-ß1 Terhadap
Penyakit Ginjal. Sari Pediatri, Juni 2011; (13): 1
15. Tisna Tyasasmaya, Dhirgo Adji. Peranan Transforming Growth Factor β-1
(TGF β-1) dalam Perkembangan Penyakit Jantung Akibat Induksi Diet
Lemak Tinggi. Jurnal Sains Veteriner. Juli 2012; 30 (1): 0126 – 0421.
16. Hyun Soon Lee. Pathogenic Role of TGF-β in Diabetic Nephropathy.
Diabetes & Metabolism. Lee. 2013; S9
17. Paine. SK, Basu A, Mondal LK, Sen A, Choudhuri S, Chowdhury IH, Saha
A, Bhadhuri G, Mukherjee A, Bhattacharya B. Association of vascular
endothelial growth factor, transforming growth factor beta, and interferon
gamma gene polymorphisms with proliferative diabetic retinopathy in
patients with type 2 diabetes. 2012; (18): 2749-2757.
18. M. Bîcu, M. Moţa, M. Panduru, C. Grăunţeanu, E. Moţa. Oxidative stress in
diabetic kidney disease.rom. 2010; 48 (4) 307–312
19. P.Zhang, Y.Cai, A.Soofi, and G.R. Dressler. Activation Of Wnt11 by
Transforming Growth Factor-ß Drives Mesenchymal Gene Expression
Through Non-Cononical wnt Protein Signaling In Renal Ephitelial Cells.
2012; 287(25): 21290–21302.
20. Yogesh M. S, Umesh S. D, Harini B. Mesangial Pathology in Glomerular
Disease. Targets for teraupetic intervention. 2010; 1337-1343.
21. A.Ghayur and Peter J. Margetts. Transforming growth factor-beta and the
glomerular filtration barrier Kidney Res Clin Pract. 2013 March 1; 32(1): 3-
10.
84
22. K.B Gomes, K.F Rodrigues, and A.P Fernandes. The Role of Transforming
Growth Factor-Beta in Diabetic Nephropathy. Journal of Medical Genetics
Volume 2014 (2014), Article ID 180270.
23. H.Ibrahim, A.Hanim Bt Ismail, SB.Ismail, WM.Wan Bebakar. The use of
HbA1C in the diagnosis of diabetes mellitus type 2 in high risk subjects. Int J
Diabetes & Metab (2010) 18:25-28
24. WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes
Mellitus. Abbreviated Report of a WHO Consultation. 2011.
25. CM. Sultanpur, Deepa K & SV. Kumar. comprehensive review on HbA1c in
diagnosis of diabetes mellitus. July 2010; 3 (2): 0976 – 044
26. J.Prins, BB Van der meijden, EAW.Blokland, JPM.Wielders and
RJ.Kraaijenhagen. Hemoglobin disorders detected in diabetic patients by
HbA1c analysis. Ned Tijdschr Klin Chem Labgeneesk 2005; (30): 4
27. RD.Mahajan, B.Mishra. Using Glycated Hemoglobin HbA1c for diagnosis of
Diabetes mellitus: An Indian perspective. Int J Biol Med Res. 2011; 2(2):
508-512
28. Brownlee M. Banting Lecture 2004. The Pathobiology Of Diabetic
Complications. A Unfiying Mechanism Diabetes. 2005;54;1615-35.
29. C.Campos, MD, MPH,CDE. Chronic Hyperglycemia and Glucose Toxicity:
Pathology and Clinical Sequelae. November 2012; 124(6): 0032-5481, e-
1941-9260
30. V. Sharma and Sharma PL. Diabetes and Metabolism. Role of Different
Molecular Pathways in the Development of Diabetes-Induced Nephropathy. J
Diabetes Metab 2013, (9)
31. Vilsu P. Patel, V. Lambole, B. N. Shah, P. Shah and Dhiren P. Shah.A Review
On Oxidative Stress And Diabetic Complications. 1 Apr-Jul 2013; 4 (3):
0976-7908
32. S. de M. Bandeira, L.José S. da Fonseca, Glaucevane da S. G. Luíza A.
Rabelo, Marília O. F. Goulart, and SML. Vasconcelos. Oxidative Stress as an
85
Underlying Contributor in the Development of Chronic Complications in
Diabetes Mellitus.
33. H. Kobori, M. Nangaku, G. Navar, and A. Nishiyama. The Intrarenal Renin-
Angiotensin System: From Physiology to the Pathobiology of Hypertension
and Kidney Disease. Pharmacol Rev. 2007 September; 59(3): 251–287
34. Depkes RI. Materia Medika Indonesia. Jakarta : Depkes RI, 1980.
35. Murhadi, Suharyono AS, Susilawati. Aktivitas antibakteri ekstrak daun salam
(Syzygium polyantha) dan daun pandan (pandanus amaryllifollus). 2007;
18:(1)
36. A.Sumono, A.Wulan SD. The Use of Bay Leaf (Eugenia polyantha Wight) in
Densitry. Majalah Kedokteran Gigi. July-September 2008; 41(3)
37. Mun’im A, Hanani E. Fisioterapi Dasar. Jakarta: Dian Rakyat.
38. Yohana ANA. Khasiat Tanaman Obat. Jakarta : Pustaka Buku Murah, 2008.
39. Herra Studiwan dan Mulja Hadi Santosa. Uji Aktivitas Penurun Kadar
Glukosa Darah Ekstrak Daun Eugenia polyantha pada Mencit yang Diinduksi
Aloksan. Media Kedokteran Hewan. Mei 2005; 21(2) .
40. Melhelm MF, Craven PA, Liachenko J and Derubertis FR. α-Lipoic Acid
Attenuates Hyperglycemia and Prevents Glomerular Mesangial Matrix
Expansion in Diabetes. 2002; 13: 108-16.
41. Makhyan Jibril Al-Farabi. Antibodi terhadap Advanced Glycation End
Product, Cara Mutakhir Pencegahan Komplikasi Diabetes Melitus. CDK-210.
2013; 40(11).
42. Kusuma IW, Kuspradi H, Arung ET, et al. Biological activity and
phytochemical analysis of three Indonesian medical plants, Murraya koenigii,
Syzygium polyanthum and Zingiber purpurae. Elsevier. 2011 Jan;4(1) :
75−79.
43. Rini Handayani, Joko Sulistyo. 2008. Sintesis senyawa flavonoid-α-glikosida
secara reaksi transglikosilasi enzimatik dan aktivitasnya sebagai antioksidan.
B i o d i v e r s i t a s. januari 2008; 9 (1412-033) 1: 1-4.
44. A.Redha. Flavonoid : struktur, Sifat Antioksidan dan peranannya dalam
sistem biologis. Sep. 2010; 9 (2): 196-202
86
45. Ratna Handayani, L. B. S Kardono, Jovita Merilla Wulansari. Aktivitas
antihiperglikemia pada functional drink daun salam (eugenia polyantha)
sebagai inhibitor enzim α-glukosidase. Oktober 2006; 4 (2): 1-4
46. Wahyu W, Ratu S, Rymond R, Marlinda S. Penapisan Aktivitas Superoksida
Dismutase pada Berbagai Tanaman. Juli 2005; 5(1): 2-15.
47. Vienna Saraswaty. Alpha Glucosidase Inhibitory Activity From Syzigium sp.
Teknologi Indonesia 2010; 33(1): 33–37.
48. Alejandro D. Bolzán, Martha S. Bianchi. Genotoxicity of Streptozotocin.
Mutation Research .2002. (512) 121–134
49. N.Sakata, G.Yoshimatsu, H.Tsuchiya, S.Egawa, and M.Unno. Review Article
Animal Models of Diabetes Mellitus for Islet Transplantation. 12 December
2012;
50. J.G. Mabley, Wilma L.S.Pinzon, G.R. Hasko , Andrew L. Salzman, A.
Rabinovitch, E.Kun & C.SzaboÂ. Inhibition of poly (ADP-ribose) synthetase
by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone
protects mice from multiple-low-dose streptozotocin-induced diabetes. 2001
133: 909 – 919
51. Melanie L Graham, Jody L Janecek, Jessica A Kittredge, Bernhard J Hering,
and Henk-Jan Schuurman. The Streptozotocin-Induced Diabetic Nude Mouse
Model: Differences between Animals from Different Sources. August 2011;
61(4): 356–360
52. Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi S, Farhangi A, Allah A,
Mofidian S, Lame Rad B. Induction of diabetes by streptozotocin in rats.
2007; 22: 60-64
53. Sastroasmoro S dan Ismail. Dasar-dasar metodologi penelitian klinis. Edisi 3.
Jakarta : Sagung Seto, 2008 : 93-111.
54. Cha DR, Kang YS, Sang Youb Han YHJea. Vascular Endothelial Growth
Factor is Increased During Early Stage of Diabetic Nephrophaty in Tipe II
Diabetic Rats. 2004; 81-84
55. Arora S, Ojha SK, Vohora D. Characterisation of Streptozotocin Induced
Diabetes Melitus in Swiss Albino Mice. 2009; 3(2): 81-4.
87
56. Nakagawa, T., Kosugi, T., Haneda, M., Rivard, C. J. & Long, D. A.,
Abnormal Angiogenesis in Diabetic Nephropathy. Diabetes Journal 58,
1471-1478 (2009).